Amendments to the Note. The Holder and the Company hereby amend the Note as follows: (a) Upon the closing of the Listing, all amounts of principal and interest on the Note shall automatically convert into a number of shares of common stock of the Company determined by dividing the outstanding principal amount plus all accrued and unpaid interest by the price per share in the Listing; and (b) The Holder agrees that, in connection with the conversion of the Note at the closing of the Listing, the Holder will execute all necessary documents in connection with the Listing reasonably requested by the Company.
Appears in 4 contracts
Samples: 6% Unsecured Promissory Note (Vitro Biopharma, Inc.), 4% Unsecured Promissory Note (Vitro Biopharma, Inc.), 4% Unsecured Promissory Note (Vitro Biopharma, Inc.)
